RECRUITING

ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. - Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. - Determine if there is a significant effect on reported pain levels with the use of an ESP block vs. saline control in post percutaneous nephrolithotomies.

Official Title

Erector Spinae Plane Block Versus Control for Pain Control Following Percutaneous Nephrolithotomy: A Randomized, Double-Blind, Placebo Controlled Study

Quick Facts

Study Start:2021-08-09
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05024344

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM.
  2. * Female participants of childbearing potential will be required to provide a negative pregnancy test.
  3. * Ability to understand and teach back consent for the procedure.
  4. * Willingness to sign consent for procedure.
  5. * English speaking.
  1. * Emergent surgery status.
  2. * Local infection
  3. * Allergy to local anesthetics.
  4. * Recreational drug use.
  5. * Inability to provide informed consent.
  6. * Pregnancy or breastfeeding.
  7. * History of Guillain-Barre' Syndrome.
  8. * Underlying medical conditions that would post a significant risk to the patient.
  9. * Opioid use \>90 days in the year leading up to surgery.

Contacts and Locations

Study Contact

Jason Buehler, MD
CONTACT
865-305-9220
jbuehler@utmck.edu
Aimee Pehrson
CONTACT
865-305-5432
apehrson@utmck.edu

Principal Investigator

Jason Buehler, MD
PRINCIPAL_INVESTIGATOR
University of Tennessee Medical Center

Study Locations (Sites)

University of Tennessee Medical Center
Knoxville, Tennessee, 37920
United States

Collaborators and Investigators

Sponsor: University of Tennessee Medical Center

  • Jason Buehler, MD, PRINCIPAL_INVESTIGATOR, University of Tennessee Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-08-09
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2021-08-09
Study Completion Date2026-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Nephrolithotomy, Percutaneous